| # | Drug | Count |
|---|---|---|
| 0 | VEDOLIZUMAB | 52 |
| 1 | PREDNISONE | 36 |
| 2 | ERGOCALCIFEROL | 35 |
| 3 | ACETAMINOPHEN | 34 |
| 4 | OMEPRAZOLE MAGNESIUM | 29 |
| 5 | ADALIMUMAB | 28 |
| 6 | ASPIRIN | 28 |
| 7 | METHOTREXATE SODIUM | 28 |
| 8 | ASPIRIN 325 MG | 26 |
| 9 | ASPIRIN 81 MG | 26 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PAROMOMYCIN SULFATE | 4 | 0.0377 |
| 1 | HYPROMELLOSE 2208 (15000 MPA.S) | 1 | 0.0233 |
| 2 | DEXTRAN 40 | 1 | 0.0139 |
| 3 | POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE | 1 | 0.0061 |
| 4 | CASTOR OIL | 1 | 0.0052 |
| 5 | MIRIKIZUMAB-MRKZ | 3 | 0.0033 |
| 6 | POTASSIUM IODIDE | 4 | 0.0027 |
| 7 | CORTISOL | 1 | 0.0025 |
| 8 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | 3 | 0.0023 |
| 9 | FLUTEMETAMOL F-18 | 1 | 0.0019 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 69 |
| 1 | Corticosteroid [EPC] | 64 |
| 2 | Integrin Receptor Antagonist [EPC] | 56 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 44 |
| 4 | Proton Pump Inhibitor [EPC] | 42 |
| 5 | Provitamin D2 Compound [EPC] | 35 |
| 6 | Osmotic Laxative [EPC] | 34 |
| 7 | Aminosalicylate [EPC] | 28 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 28 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 27 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 1 | Provitamin D2 Compound [EPC] | 35 | 0.0012 |
| 2 | GLP-2 Analog [EPC] | 12 | 0.0009 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 4 | Tyrosine Kinase 2 Inhibitor [EPC] | 2 | 0.0007 |
| 5 | Integrin Receptor Antagonist [EPC] | 56 | 0.0006 |
| 6 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 7 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 8 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 9 | Non-Standardized Insect Allergenic Extract [EPC] | 2 | 0.0003 |